Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit
Update: 2025-11-04
Description
Pfizer and Novo Nordisk engage in a legal battle over Metsera, a biotech firm developing next-generation obesity treatments. Pfizer accuses Novo of stalling instead of acquiring Metsera, while Novo insists it's playing by the rules. The outcome of this court battle could significantly impact the future of obesity medicine.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
